Outcome | Grade | Studies | ||||||
---|---|---|---|---|---|---|---|---|
Skin Density |
C
|
|
||||||
Skin Hydration |
C
|
|
||||||
Skin Smoothness |
C
|
|
||||||
Hyperpigmentation |
C
|
|
||||||
Wrinkles |
D
|
|
Outcome | Grade | Studies | ||||||
---|---|---|---|---|---|---|---|---|
Sebum Level |
D
|
|
Outcome | Frequency | Studies | ||||||
---|---|---|---|---|---|---|---|---|
Contact Dermatitis |
|
|
||||||
Nausea |
|
|
||||||
Cold |
|
|
||||||
Headache |
|
|
||||||
Diverticulitis |
|
|
Intervention | Imedeen Time Perfection |
---|---|
Concern | Skin Density |
Subject Type | Human |
Trial Design |
Double-Blind Randomised Controlled |
Trial Duration | 84 days |
Participants | 91 |
Intervention | Imedeen Time Perfection |
---|---|
Concern | Skin Hydration |
Subject Type | Human |
Trial Design |
Double-Blind Randomised Controlled |
Trial Duration | 84 days |
Participants | 91 |
Intervention | Imedeen Time Perfection |
---|---|
Concern | Skin Hydration |
Subject Type | Human |
Trial Design |
Open-Label Non-Randomised Uncontrolled |
Trial Duration | 120 days |
Participants | 50 |
Intervention | Imedeen Time Perfection |
---|---|
Concern | Skin Smoothness |
Subject Type | Human |
Trial Design |
Double-Blind Randomised Controlled |
Trial Duration | 84 days |
Participants | 91 |
Intervention | Imedeen Time Perfection |
---|---|
Concern | Skin Smoothness |
Subject Type | Human |
Trial Design |
Open-Label Non-Randomised Uncontrolled |
Trial Duration | 120 days |
Participants | 50 |
Intervention | Imedeen Time Perfection |
---|---|
Concern | Hyperpigmentation |
Subject Type | Human |
Trial Design |
Double-Blind Randomised Controlled |
Trial Duration | 84 days |
Participants | 91 |
Intervention | Imedeen Time Perfection |
---|---|
Concern | Hyperpigmentation |
Subject Type | Human |
Trial Design |
Open-Label Non-Randomised Uncontrolled |
Trial Duration | 120 days |
Participants | 50 |
Intervention | Imedeen Time Perfection |
---|---|
Concern | Wrinkles |
Subject Type | Human |
Trial Design |
Double-Blind Randomised Controlled |
Trial Duration | 84 days |
Participants | 91 |
Intervention | Imedeen Time Perfection |
---|---|
Concern | Wrinkles |
Subject Type | Human |
Trial Design |
Open-Label Non-Randomised Uncontrolled |
Trial Duration | 120 days |
Participants | 50 |
Intervention | Imedeen Time Perfection |
---|---|
Concern | Fine Lines |
Subject Type | Human |
Trial Design |
Double-Blind Randomised Controlled |
Trial Duration | 84 days |
Participants | 91 |
Intervention | Imedeen Time Perfection |
---|---|
Concern | Fine Lines |
Subject Type | Human |
Trial Design |
Open-Label Non-Randomised Uncontrolled |
Trial Duration | 120 days |
Participants | 50 |
Intervention | Imedeen Time Perfection |
---|---|
Concern | Under Eye Circles |
Subject Type | Human |
Trial Design |
Double-Blind Randomised Controlled |
Trial Duration | 84 days |
Participants | 91 |
Intervention | Imedeen Time Perfection |
---|---|
Concern | Skin Barrier Function |
Subject Type | Human |
Trial Design |
Double-Blind Randomised Controlled |
Trial Duration | 84 days |
Participants | 91 |
Intervention | Imedeen Time Perfection |
---|---|
Concern | Skin Brightness |
Subject Type | Human |
Trial Design |
Double-Blind Randomised Controlled |
Trial Duration | 84 days |
Participants | 91 |
Intervention | Imedeen Time Perfection |
---|---|
Concern | Skin Brightness |
Subject Type | Human |
Trial Design |
Open-Label Non-Randomised Uncontrolled |
Trial Duration | 120 days |
Participants | 50 |